PURE · Pure Bioscience, Inc. · Analyst Estimates
$0.09
+0.01 (+12.64%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our history of recurring operating losses, and negative cash flows from operating activities give rise to substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Jun 15, 2026
Market Cap
$11.70M
Shares
130.02M
Volume · Oct 23
22.5K
Avg daily vol (3M)
31.87K
Analyst Estimates
Compare analyst forecasts for Pure Bioscience, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 04:43 UTC · Publication dates shown per estimate · 2 metric / period groups
FY ending 2018-07-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|
Q ending 2018-10-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|